CTC Capital Management’s Amgen AMGN Stock Holding History

CTC Capital Management’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-3,400	Closed	-$766K	–	104
2022 Q3	$766K	Buy	3,400 +1,900	+127%	+$461K	0.61%	37
2022 Q2	$365K	Buy	+1,500	New	+$368K	0.4%	47

Other funds holding AMGN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

AWA

Arete Wealth Advisors Chicago, Illinois $1.33B AUM 25.12% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

CTC Capital Management's AMGN Position: Q4 2022 in Review

CTC Capital Management sold out of Amgen (AMGN) in Q4 2022, closing a stake of 3,400 shares — an estimated $766K sold.

CTC Capital Management first reported a position in AMGN in Q2 2022 and held it in 2 quarters. The position peaked at $766K in Q3 2022. 2,501 funds tracked by Wall St. Rank hold AMGN as of Q4 2022.

CTC Capital Management reported no remaining Amgen position as of Q4 2022 after selling out during the quarter.
CTC Capital Management sold 3,400 Amgen shares in Q4 2022, an estimated $766K.
CTC Capital Management first reported a position in Amgen in Q2 2022 and held it in 2 quarters.
CTC Capital Management's Amgen position peaked at $766K in Q3 2022.
2,501 funds tracked by Wall St. Rank held Amgen as of Q4 2022.

Based on CTC Capital Management's 13F filing for Q4 2022, filed 13 Feb 2023.